These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20009786)

  • 1. Multimethod adherence assessment in children with perinatally acquired HIV-1: the influence of off-schedule dosing in predicting biological markers.
    Garvie PA; Wilkins ML; Kolivas ED; Young JC
    Pediatr Infect Dis J; 2010 Apr; 29(4):372-4. PubMed ID: 20009786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence in adolescents with behaviorally-acquired HIV: evidence for using a multimethod assessment protocol.
    Garvie PA; Wilkins ML; Young JC
    J Adolesc Health; 2010 Nov; 47(5):504-11. PubMed ID: 20970086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a practical method to assess antiretroviral adherence in HIV-infected Thai children.
    Plipat N; Kottapat U; Komoltri C; Voradilokkul J; Anansakunwatt W; Chearskul P; Lapphra K; Phongsamart W; Chearskul S; Chokephaibulkit K; Vanprapar N
    Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):828-34. PubMed ID: 18041298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS.
    Garvie PA; Lensing S; Rai SN
    Pediatrics; 2007 Apr; 119(4):e893-9. PubMed ID: 17353298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors of treatment interruption duration in a cohort of HIV-1 infected patients with CD4 count greater than 350 cells per mm3.
    Fillaux J; Delpierre C; Alvarez M; Jaafar A; Marchou B; Massip P; Cuzin L
    Med Mal Infect; 2006 Jun; 36(6):335-9. PubMed ID: 16631330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
    AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
    Williams PL; Storm D; Montepiedra G; Nichols S; Kammerer B; Sirois PA; Farley J; Malee K;
    Pediatrics; 2006 Dec; 118(6):e1745-57. PubMed ID: 17101712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between caregiver knowledge of antiretroviral therapy regimens and disease parameters among perinatally human immunodeficiency virus-infected children.
    Nicholson O; Mellins C; Dolezal C; Santamaria EK; Brackis-Cott E; Abrams EJ
    Arch Pediatr Adolesc Med; 2006 Dec; 160(12):1307-8. PubMed ID: 17146031
    [No Abstract]   [Full Text] [Related]  

  • 10. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
    Grossberg R; Zhang Y; Gross R
    J Clin Epidemiol; 2004 Oct; 57(10):1107-10. PubMed ID: 15528063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once daily dosing improves adherence to antiretroviral therapy.
    Raboud J; Li M; Walmsley S; Cooper C; Blitz S; Bayoumi AM; Rourke S; Rueda S; Rachlis A; Mittmann N; Smieja M; Collins E; Loutfy MR
    AIDS Behav; 2011 Oct; 15(7):1397-409. PubMed ID: 20878227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of previous and present World Health Organization clinical staging criteria in HIV-infected Malawian children.
    Poerksen G; Nyirenda M; Pollock L; Blencowe H; Tembo P; Chesshyre E; Jefferis O; Kenny J; Moons P; Bunn J; Molyneux E
    AIDS; 2009 Sep; 23(14):1913-6. PubMed ID: 19584702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off/12 weeks on therapy in children having a chronically undetectable viral load cause progressively smaller viral rebounds.
    Palacios GC; Sanchez LM; Briones E; Ramirez TJ; Castillo H; Rivera LG; Vazquez CA; Rodriguez-Padilla C; Holodniy M
    Int J Infect Dis; 2010 Jan; 14(1):e34-40. PubMed ID: 19467895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.
    Chiappini E; Galli L; Tovo PA; Gabiano C; Gattinara GC; Guarino A; Badolato R; Giaquinto C; Lisi C; de Martino M;
    AIDS; 2006 Jan; 20(2):207-15. PubMed ID: 16511413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia.
    Beyene KA; Gedif T; Gebre-Mariam T; Engidawork E
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1007-15. PubMed ID: 19650153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response.
    Nieuwkerk P; Gisolf E; Sprangers M; Danner S;
    Antivir Ther; 2001 Jun; 6(2):97-103. PubMed ID: 11491422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients].
    Salmon-Céron D; Deleuze J; Coste J; Guerin C; Ginsburg C; Blanche P; Finkielsztejn L; Pecqueux L; Chaput S; Gorin I; Sicard D
    Ann Med Interne (Paris); 2000 Jun; 151(4):297-302. PubMed ID: 10922958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with incomplete virological response to highly active antiretroviral therapy.
    Welch K; Morse A; Clark R; Ogbuokiri T
    Clin Infect Dis; 2000 Feb; 30(2):407-8. PubMed ID: 10671360
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on antiretroviral therapy.
    Riordan A; Bugembe T
    Arch Dis Child; 2009 Jan; 94(1):70-4. PubMed ID: 18838416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.